Related Experiment Video
Updated: Apr 4, 2026

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
[An experience of using divasa in the treatment of cerebrovascular insufficiency]
E I Chukanova1, A N Bogolepova1, A S Chukanova1
1Pirogov Russian National Research Medical University, Moscow.
Insights
Divasa effectively treats cerebrovascular insufficiency by reducing asthenic symptoms and improving quality of life. This study shows positive effects on patient well-being and safety.
Area of Science:
- Neurology
- Pharmacology
Background:
- Cerebrovascular insufficiency can lead to debilitating symptoms such as asthenia, autonomic dysfunction, and vestibular/ataxic disorders.
- Chronic cerebrovascular disease impacts patient quality of life and neurological function.
Purpose of the Study:
- To evaluate the clinical efficacy and safety of divasa in treating patients with cerebrovascular insufficiency.
- To assess the impact of divasa on asthenic, autonomic, vestibular, and ataxic symptoms.
Main Methods:
- A study involving 40 patients with chronic cerebrovascular insufficiency treated with divasa.
- Symptom severity assessed using Visual Analogue Scale (VAS), alongside neuropsychological and quality of life questionnaires (MMSE, MFI-20, HAM-A, SF-36).
- Plasma levels of fibrinogen and von Willebrand factor were measured; a control group was included for comparison.
Main Results:
- Divasa significantly reduced asthenic symptoms, anxiety, sleep disturbances, and autonomic disorders, improving patients' quality of life.
- A notable decrease and normalization of plasma fibrinogen and von Willebrand factor levels were observed.
- The drug was well-tolerated, with only 5% experiencing allergic reactions.
Conclusions:
- Divasa demonstrated a positive effect on the condition of patients with cerebrovascular insufficiency.
- The drug is recommended for inclusion in the comprehensive treatment of these patients.
- Further research may explore long-term efficacy and specific mechanisms of action.
Aim:
To evaluate the clinical efficacy and safety of divasa in the treatment of patients with cerebrovascular insufficiency.
Material And Methods:
The main group included 40 patients (mean age 56.2±5.7 years) with asthenic/autonomic and vestibular/ataxic disorders developed during chronic cerebrovascular disease. The severity of symptoms was measured with the Visual Analogue scale (VAS). Neuropsychological and psychoemotional status was assessed with MMSE, MFI-20, HAM-A, a subjective sleep questionnaire, a scheme for detection of signs of autonomic disorders. Quality of life questionnaire (SF-36) and CGI scale were used as well. The plasma levels of fibrinogen and the von Willebrand factor were determined in all patients. The control group included 40 patients with chronic cerebrovascular insufficiency matched for age, sex and severity of neurological symptoms to the main group.
Results:
The scores of asthenic symptoms, anxiety, sleep disorders and autonomic disorders were decreased significantly that led to the improvement of quality of life of patients. A significant decrease and normalization of the plasma levels of fibrinogen and the von Willebrand factor were identified in the patients of the main group. The drug was well-tolerated, side-effects (allergic reactions) were noted only in 5%.
Conclusion:
The positive effect of divasa on patient's condition was demonstrated. The drug may be recommended for the use in complex treatment of these patients.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Intrauterine Drug Delivery Systems
Current Dividers
Peritoneal Dialysis I: Introduction and Procedure
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Esophageal Varices-I: Introduction

